{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "29",
                "@timestamp": "2021-01-29T03:39:48.000048-05:00",
                "@year": "2021",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "21",
                "@year": "2019",
                "@month": "02"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Seres Therapeutics"},
                {
                    "xocs:funding-agency-matched-string": "Amgen",
                    "xocs:funding-agency": "Amgen",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002429",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Pfizer",
                    "xocs:funding-agency": "Pfizer",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004319",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Genentech",
                    "xocs:funding-agency": "Genentech",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004328",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Gilead",
                    "xocs:funding-agency": "Gilead Sciences",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005564",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Janssen",
                    "xocs:funding-agency": "Janssen Biotech",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005565",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "AbbVie",
                    "xocs:funding-agency": "AbbVie",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006483",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Takeda",
                    "xocs:funding-agency-acronym": "TPUSA",
                    "xocs:funding-agency": "Takeda Pharmaceuticals U.S.A.",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007723",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Allergan",
                    "xocs:funding-agency": "Allergan",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007819",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2963597/"
                },
                {
                    "xocs:funding-agency-matched-string": "UCB",
                    "xocs:funding-agency-acronym": "UCB",
                    "xocs:funding-agency": "School of Public Health, University of California Berkeley",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100011944",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "MedImmune",
                    "xocs:funding-agency": "MedImmune",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004628",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-02-03T17:13:50.082771Z",
            "xocs:funding-text": "Conflicts of interest: EVL has consulted for Takeda, Janssen, AbbVie, UCB, Amgen, Pfizer, Celgene, Eli Lilly, Celltrion Healthcare, and Napo Pharmaceuticals. EVL has received research support from Takeda, Janssen, AbbVie, UCB, Amgen, Pfizer, Celgene, Receptos, Genentech, Gilead, Seres Therapeutics, MedImmune, Allergan, and Robarts Clinical Trials. LR has consulted for Ferring Pharmaceuticals, honorarium paid to Mayo Clinic. The rest of the authors have no relevant disclosures.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "address-part": "200 First Street, S.W.",
                            "postal-code": "55905",
                            "@afid": "60005558",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": [
                                {"$": "Division of Gastroenterology and Hepatology"},
                                {"$": "Mayo Clinic"}
                            ],
                            "affiliation-id": {
                                "@afid": "60005558",
                                "@dptid": "109429459"
                            },
                            "state": "MN",
                            "@dptid": "109429459"
                        },
                        "author": [
                            {
                                "ce:given-name": "Badr",
                                "preferred-name": {
                                    "ce:given-name": "Badr",
                                    "ce:initials": "B.",
                                    "ce:surname": "Al-Bawardy",
                                    "ce:indexed-name": "Al-Bawardy B."
                                },
                                "@seq": "1",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Al-Bawardy",
                                "@auid": "56217996100",
                                "ce:indexed-name": "Al-Bawardy B."
                            },
                            {
                                "ce:given-name": "Sang Hyoung",
                                "preferred-name": {
                                    "ce:given-name": "Sang Hyoung",
                                    "ce:initials": "S.H.",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park S.H."
                                },
                                "@seq": "5",
                                "ce:initials": "S.H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Park",
                                "@auid": "34977204700",
                                "ce:indexed-name": "Park S.H."
                            },
                            {
                                "ce:given-name": "Satimai",
                                "preferred-name": {
                                    "ce:given-name": "Satimai",
                                    "ce:initials": "S.",
                                    "ce:surname": "Aniwan",
                                    "ce:indexed-name": "Aniwan S."
                                },
                                "@seq": "6",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Aniwan",
                                "@auid": "36010544000",
                                "ce:indexed-name": "Aniwan S."
                            },
                            {
                                "ce:given-name": "Shayla A.",
                                "preferred-name": {
                                    "ce:given-name": "Shayla A.",
                                    "ce:initials": "S.A.",
                                    "ce:surname": "Schoenoff",
                                    "ce:indexed-name": "Schoenoff S.A."
                                },
                                "@seq": "7",
                                "ce:initials": "S.A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Schoenoff",
                                "@auid": "57204044045",
                                "ce:indexed-name": "Schoenoff S.A."
                            },
                            {
                                "ce:given-name": "David H.",
                                "preferred-name": {
                                    "ce:given-name": "David H.",
                                    "ce:initials": "D.H.",
                                    "ce:surname": "Bruining",
                                    "ce:indexed-name": "Bruining D.H."
                                },
                                "@seq": "8",
                                "ce:initials": "D.H.",
                                "@date-locked": "2019-09-07T06:38:22.289",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Bruining",
                                "@auid": "16833358400",
                                "ce:indexed-name": "Bruining D.H."
                            },
                            {
                                "ce:given-name": "Konstantinos A.",
                                "preferred-name": {
                                    "ce:given-name": "Konstantinos A.",
                                    "ce:initials": "K.A.",
                                    "ce:surname": "Papadakis",
                                    "ce:indexed-name": "Papadakis K.A."
                                },
                                "@seq": "9",
                                "ce:initials": "K.A.",
                                "@date-locked": "2019-07-09T16:04:43.055",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Papadakis",
                                "@auid": "19335444300",
                                "ce:indexed-name": "Papadakis K.A."
                            },
                            {
                                "ce:given-name": "Laura",
                                "preferred-name": {
                                    "ce:given-name": "Laura",
                                    "ce:initials": "L.",
                                    "ce:surname": "Raffals",
                                    "ce:indexed-name": "Raffals L."
                                },
                                "@seq": "10",
                                "ce:initials": "L.",
                                "@date-locked": "2019-07-09T16:04:43.055",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Raffals",
                                "@auid": "54986410100",
                                "ce:indexed-name": "Raffals L."
                            },
                            {
                                "ce:given-name": "William J.",
                                "preferred-name": {
                                    "ce:given-name": "William J.",
                                    "ce:initials": "W.J.",
                                    "ce:surname": "Tremaine",
                                    "ce:indexed-name": "Tremaine W.J."
                                },
                                "@seq": "11",
                                "ce:initials": "W.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Tremaine",
                                "@auid": "7006301261",
                                "ce:indexed-name": "Tremaine W.J."
                            },
                            {
                                "ce:given-name": "Edward V.",
                                "preferred-name": {
                                    "ce:given-name": "Edward V.",
                                    "ce:initials": "E.V.",
                                    "ce:surname": "Loftus",
                                    "ce:indexed-name": "Loftus E.V."
                                },
                                "@seq": "12",
                                "ce:initials": "E.V.",
                                "@date-locked": "2019-07-09T16:04:43.055",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Loftus",
                                "@auid": "7202138774",
                                "ce:suffix": "Jr.",
                                "ce:indexed-name": "Loftus E.V."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60005558",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Mayo Clinic"}
                            ],
                            "affiliation-id": {
                                "@afid": "60005558",
                                "@dptid": "113092165"
                            },
                            "state": "MN",
                            "@dptid": "113092165"
                        },
                        "author": [{
                            "ce:given-name": "Guilherme Piovezani",
                            "preferred-name": {
                                "ce:given-name": "Guilherme Piovezani",
                                "ce:initials": "G.P.",
                                "ce:surname": "Ramos",
                                "ce:indexed-name": "Ramos G.P."
                            },
                            "@seq": "2",
                            "ce:initials": "G.P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Ramos",
                            "@auid": "57189043639",
                            "ce:indexed-name": "Ramos G.P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60005558",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": [
                                {"$": "Department of Laboratory Medicine and Pathology"},
                                {"$": "Mayo Clinic"}
                            ],
                            "affiliation-id": {
                                "@afid": "60005558",
                                "@dptid": "113717257"
                            },
                            "state": "MN",
                            "@dptid": "113717257"
                        },
                        "author": [{
                            "ce:given-name": "Maria Alice V.",
                            "preferred-name": {
                                "ce:given-name": "Maria Alice V.",
                                "ce:initials": "M.A.V.",
                                "ce:surname": "Willrich",
                                "ce:indexed-name": "Willrich M.A.V."
                            },
                            "@seq": "3",
                            "ce:initials": "M.A.V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "Ph.D.",
                            "ce:surname": "Willrich",
                            "@auid": "56736400500",
                            "ce:indexed-name": "Willrich M.A.V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60005558",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": [
                                {"$": "Division of Biomedical Statistics and Informatics"},
                                {"$": "Mayo Clinic"}
                            ],
                            "affiliation-id": {
                                "@afid": "60005558",
                                "@dptid": "103323932"
                            },
                            "state": "MN",
                            "@dptid": "103323932"
                        },
                        "author": [{
                            "ce:given-name": "Sarah M.",
                            "preferred-name": {
                                "ce:given-name": "Sarah M.",
                                "ce:initials": "S.M.",
                                "ce:surname": "Jenkins",
                                "ce:indexed-name": "Jenkins S.M."
                            },
                            "@seq": "4",
                            "ce:initials": "S.M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MS",
                            "ce:surname": "Jenkins",
                            "@auid": "34770162500",
                            "ce:indexed-name": "Jenkins S.M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60006240",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Gastroenterology"},
                                {"$": "University of Ulsan College of Medicine"},
                                {"$": "Asan Medical Center"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60006240",
                                    "@dptid": "113669103"
                                },
                                {"@afid": "60068691"}
                            ],
                            "@dptid": "113669103"
                        },
                        "author": [{
                            "ce:given-name": "Sang Hyoung",
                            "preferred-name": {
                                "ce:given-name": "Sang Hyoung",
                                "ce:initials": "S.H.",
                                "ce:surname": "Park",
                                "ce:indexed-name": "Park S.H."
                            },
                            "@seq": "5",
                            "ce:initials": "S.H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Park",
                            "@auid": "34977204700",
                            "ce:indexed-name": "Park S.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Gastroenterology"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60028190",
                                    "@dptid": "104425746"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60022183"}
                            ],
                            "@dptid": "104425746"
                        },
                        "author": [{
                            "ce:given-name": "Satimai",
                            "preferred-name": {
                                "ce:given-name": "Satimai",
                                "ce:initials": "S.",
                                "ce:surname": "Aniwan",
                                "ce:indexed-name": "Aniwan S."
                            },
                            "@seq": "6",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Aniwan",
                            "@auid": "36010544000",
                            "ce:indexed-name": "Aniwan S."
                        }]
                    }
                ],
                "citation-title": "Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease",
                "abstracts": "© 2018 Crohn's & Colitis Foundation.Background/Aims: The clinical utility of vedolizumab (VDZ) trough levels (VTLs) in inflammatory bowel disease (IBD) is not well defined. The aims of this study are to determine the median VTLs and frequency of detected antibodies, the correlation of VTLs with C-reactive protein (CRP) and mucosal healing (MH), and the change in clinical management based on VTLs. Methods: A cross-sectional study of IBD patients treated with VDZ with VTLs checked between July 1, 2016, and March 1, 2017, was conducted. Mucosal healing was defined as absence of mucosal ulcers in Crohn's disease (CD) and Mayo endoscopic score ≤1 for ulcerative colitis (UC). Normal CRP was defined as ≤8 mg/L. Results: A total of 171 patients (62% CD, 31% UC, 7% indeterminate colitis) were included. Median VTLs was 15.3 ug/mL (range, 0-60), and 1 patient had detectable antibodies to VDZ. Patients with a normal CRP had a median VTLs of 17.3 ug/mL vs 10.7 ug/mL in high CRP patients (P = 0.046). This was noted in CD (20.3 vs 10.4 ug/mL; P = 0.005) but not in UC patients (14.4 vs 20.8; P = 0.72). Mucosal healing was achieved in 35% of patients (37 of 105); among these, median VTLs was 13.7 ug/mL vs 16.1 ug/mL in patients who did not achieve MH (P = 0.64). Vedolizumab trough levels resulted in a change in clinical management in 73%. Conclusions: Our cohort showed a low rate of immunogenicity to VDZ and an association between VTLs and CRP in CD but not in UC patients. No relationship between VTLs and MH was detected. Vedolizumab trough level measurements altered management in approximately three fourths of patients.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "address-part": "200 First Street, S.W.",
                        "postal-code": "55905",
                        "@country": "usa",
                        "city": "Rochester",
                        "organization": [
                            {"$": "Division of Gastroenterology and Hepatology"},
                            {"$": "Mayo Clinic"}
                        ],
                        "state": "MN"
                    },
                    "person": {
                        "ce:given-name": "Edward V.",
                        "ce:initials": "E.V.",
                        "ce:degrees": "MD",
                        "ce:surname": "Loftus",
                        "ce:suffix": "Jr.",
                        "ce:indexed-name": "Loftus E.V."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "inflammatory bowel disease",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "therapeutic drug monitoring",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "vedolizumab",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://academic.oup.com/ibdjournal/issue",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Inflammatory Bowel Diseases",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "25",
                            "@issue": "3"
                        },
                        "pagerange": {
                            "@first": "580",
                            "@last": "586"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Inflammatory Bowel Diseases",
                    "publicationdate": {
                        "month": "02",
                        "year": "2019",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "21 February 2019"
                        },
                        "day": "21"
                    },
                    "codencode": "IBDNB",
                    "sourcetitle-abbrev": "Inflammatory Bowel Dis.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "15364844",
                            "@type": "electronic"
                        },
                        {
                            "$": "10780998",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2019"},
                    "publisher": {"publishername": "Oxford University Press"},
                    "@srcid": "28387"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2723"},
                                {"$": "2715"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "446-86-6",
                                    "chemical-name": "azathioprine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "51333-22-3"},
                                        {"$": "51372-29-3"}
                                    ],
                                    "chemical-name": "budesonide"
                                },
                                {
                                    "cas-registry-number": "9007-41-4",
                                    "chemical-name": "C reactive protein"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "31441-78-8"},
                                        {"$": "50-44-2"},
                                        {"$": "6112-76-1"}
                                    ],
                                    "chemical-name": "mercaptopurine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "15475-56-6"},
                                        {"$": "59-05-2"},
                                        {"$": "7413-34-5"},
                                        {"$": "7532-09-4"},
                                        {"$": "6745-93-3"}
                                    ],
                                    "chemical-name": "methotrexate"
                                },
                                {
                                    "cas-registry-number": "53-03-2",
                                    "chemical-name": "prednisone"
                                },
                                {
                                    "cas-registry-number": "943609-66-3",
                                    "chemical-name": "vedolizumab"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antibodies, Monoclonal, Humanized"},
                                {"chemical-name": "Biomarkers"},
                                {"chemical-name": "Gastrointestinal Agents"},
                                {"chemical-name": "vedolizumab"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "12",
                    "@timestamp": "BST 08:55:10",
                    "@year": "2021",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "627836640",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "626491059",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "917678318",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20190390689",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "30165638",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20191071925",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20191614206",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85061989001",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85061989001",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "626491059",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76902399",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1093/ibd/izy272"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "30",
                "reference": [
                    {
                        "ref-fulltext": "Reinink AR, Lee TC, Higgins PD. Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis. 2016;22:1859-1869.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: A meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84979920410",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "1859",
                                    "@last": "1869"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Reinink",
                                    "ce:indexed-name": "Reinink A.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee T.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Higgins",
                                    "ce:indexed-name": "Higgins P.D."
                                }
                            ]},
                            "ref-sourcetitle": "Inflamm Bowel Dis."
                        }
                    },
                    {
                        "ref-fulltext": "Shah SC, Colombel JF, Sands BE, et al. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. Aliment Pharmacol Ther. 2016;43:317-333.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Systematic review with meta-analysis: Mucosal healing is associated with improved long-term outcomes in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84955349443",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "317",
                                    "@last": "333"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah S.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel J.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands B.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther."
                        }
                    },
                    {
                        "ref-fulltext": "Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61:1619-1635.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Mucosal healing in inflammatory bowel diseases: A systematic review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84867027990",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "1619",
                                    "@last": "1635"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Neurath",
                                    "ce:indexed-name": "Neurath M.F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Travis",
                                    "ce:indexed-name": "Travis S.P."
                                }
                            ]},
                            "ref-sourcetitle": "Gut"
                        }
                    },
                    {
                        "ref-fulltext": "Casellas F, Barreiro de Acosta M, Iglesias M, et al. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2012;24:762-769.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862231137",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "762",
                                    "@last": "769"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Casellas",
                                        "ce:indexed-name": "Casellas F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Barreiro-De-Acosta",
                                        "ce:indexed-name": "Barreiro-De-Acosta M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Iglesias",
                                        "ce:indexed-name": "Iglesias M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Gastroenterol Hepatol."
                        }
                    },
                    {
                        "ref-fulltext": "Maser EA, Villela R, Silverberg MS, et al. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:1248-1254.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33749432435",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "1248",
                                    "@last": "1254"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Maser",
                                        "ce:indexed-name": "Maser E.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Villela",
                                        "ce:indexed-name": "Villela R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Silverberg",
                                        "ce:indexed-name": "Silverberg M.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol."
                        }
                    },
                    {
                        "ref-fulltext": "Seow CH, Newman A, Irwin SP, et al. Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut. 2010;59:49-54.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Trough serum infliximab: A predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "73449088039",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "49",
                                    "@last": "54"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Seow",
                                        "ce:indexed-name": "Seow C.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Newman",
                                        "ce:indexed-name": "Newman A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Irwin",
                                        "ce:indexed-name": "Irwin S.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        }
                    },
                    {
                        "ref-fulltext": "Chiu YL, Rubin DT, Vermeire S, et al. Serum adalimumab concentration and clinical remission in patients with Crohn's disease. Inflamm Bowel Dis. 2013;19:1112-1122.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Serum adalimumab concentration and clinical remission in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84879197786",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "1112",
                                    "@last": "1122"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Chiu",
                                        "ce:indexed-name": "Chiu Y.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Rubin",
                                        "ce:indexed-name": "Rubin D.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Vermeire",
                                        "ce:indexed-name": "Vermeire S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis."
                        }
                    },
                    {
                        "ref-fulltext": "Zittan E, Kabakchiev B, Milgrom R, et al. Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn's disease. J Crohns Colitis. 2016;10:510-515.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84982199930",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "510",
                                    "@last": "515"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Zittan",
                                        "ce:indexed-name": "Zittan E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Kabakchiev",
                                        "ce:indexed-name": "Kabakchiev B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Milgrom",
                                        "ce:indexed-name": "Milgrom R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis."
                        }
                    },
                    {
                        "ref-fulltext": "Yarur AJ, Jain A, Hauenstein SI, et al. Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22:409-415.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn's disease and ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84955604767",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "409",
                                    "@last": "415"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Yarur",
                                        "ce:indexed-name": "Yarur A.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Jain",
                                        "ce:indexed-name": "Jain A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Hauenstein",
                                        "ce:indexed-name": "Hauenstein S.I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis."
                        }
                    },
                    {
                        "ref-fulltext": "Ungar B, Levy I, Yavne Y, et al. Optimizing anti-TNF-α therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2016;14:550-557.e2.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Optimizing anti-TNF-α therapy: Serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84960799161",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "550",
                                    "@last": "557"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Ungar",
                                        "ce:indexed-name": "Ungar B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Levy",
                                        "ce:indexed-name": "Levy I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yavne",
                                        "ce:indexed-name": "Yavne Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol."
                        }
                    },
                    {
                        "ref-fulltext": "Mitrev N, Vande Casteele N, Seow CH, et al.; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;46:1037-1053.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Review article: Consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85031325690",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "1037",
                                    "@last": "1053"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Mitrev",
                                        "ce:indexed-name": "Mitrev N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Vande-Casteele",
                                        "ce:indexed-name": "Vande-Casteele N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Seow",
                                        "ce:indexed-name": "Seow C.H."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group",
                                    "ce:indexed-name": "IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther."
                        }
                    },
                    {
                        "ref-fulltext": "Feuerstein JD, Nguyen GC, Kupfer SS, et al.; American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on therapeutic drug monitoring in inflammatory bowel disease. Gastroenterology. 2017;153:827-834.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "American Gastroenterological Association Institute guideline on therapeutic drug monitoring in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85028810296",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "153"},
                                "pagerange": {
                                    "@first": "827",
                                    "@last": "834"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Feuerstein",
                                        "ce:indexed-name": "Feuerstein J.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Nguyen",
                                        "ce:indexed-name": "Nguyen G.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kupfer",
                                        "ce:indexed-name": "Kupfer S.S."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "American Gastroenterological Association Institute Clinical Guidelines Committee",
                                    "ce:indexed-name": "American Gastroenterological Association Institute Clinical Guidelines Committee"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        }
                    },
                    {
                        "ref-fulltext": "Feagan BG, Rutgeerts P, Sands BE, et al.; GEMINI 1 Study Group. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369:699-710.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Vedolizumab as induction and maintenance therapy for ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84882769357",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "369"},
                                "pagerange": {
                                    "@first": "699",
                                    "@last": "710"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan B.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands B.E."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "GEMINI 1 Study Group",
                                    "ce:indexed-name": "GEMINI 1 Study Group"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med."
                        }
                    },
                    {
                        "ref-fulltext": "Sandborn WJ, Feagan BG, Rutgeerts P, et al.; GEMINI 2 Study Group. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013;369:711-721.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Vedolizumab as induction and maintenance therapy for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84882749768",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "369"},
                                "pagerange": {
                                    "@first": "711",
                                    "@last": "721"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn W.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan B.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "GEMINI 2 Study Group",
                                    "ce:indexed-name": "GEMINI 2 Study Group"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med."
                        }
                    },
                    {
                        "ref-fulltext": "Sands BE, Feagan BG, Rutgeerts P, et al. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed. Gastroenterology. 2014;147:618-627.e3.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84906569062",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "147"},
                                "pagerange": {
                                    "@first": "618",
                                    "@last": "627"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands B.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan B.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        }
                    },
                    {
                        "ref-fulltext": "Vermeire S, Loftus EV Jr, Colombel JF, et al. Long-term efficacy of vedolizumab for Crohn's disease. J Crohns Colitis. 2017;11:412-424.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Long-term efficacy of vedolizumab for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85029103096",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "412",
                                    "@last": "424"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Vermeire",
                                        "ce:indexed-name": "Vermeire S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Loftus",
                                        "ce:suffix": "Jr.",
                                        "ce:indexed-name": "Loftus E.V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel J.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis."
                        }
                    },
                    {
                        "ref-fulltext": "Loftus EV Jr, Colombel JF, Feagan BG, et al. Long-term efficacy of vedolizumab for ulcerative colitis. J Crohns Colitis. 2017;11:400-411.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Long-term efficacy of vedolizumab for ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019608509",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "400",
                                    "@last": "411"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Loftus",
                                        "ce:suffix": "Jr.",
                                        "ce:indexed-name": "Loftus E.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel J.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan B.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis."
                        }
                    },
                    {
                        "ref-fulltext": "Williet N, Boschetti G, Fovet M, et al. Association between low trough levels of vedolizumab during induction therapy for inflammatory bowel diseases and need for additional doses within 6 months. Clin Gastroenterol Hepatol. 2017;15:1750-1757.e3.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Association between low trough levels of vedolizumab during induction therapy for inflammatory bowel diseases and need for additional doses within 6 months"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85032913135",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "1750",
                                    "@last": "1757"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Williet",
                                        "ce:indexed-name": "Williet N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Boschetti",
                                        "ce:indexed-name": "Boschetti G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fovet",
                                        "ce:indexed-name": "Fovet M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol."
                        }
                    },
                    {
                        "ref-fulltext": "Chao CY, Restellini S, Lemieux C, et al. P518 Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease. J Crohns Colitis. 2018;12:S367-S368.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "P518 Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071058833",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "S367",
                                    "@last": "S368"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Chao",
                                        "ce:indexed-name": "Chao C.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Restellini",
                                        "ce:indexed-name": "Restellini S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lemieux",
                                        "ce:indexed-name": "Lemieux C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis."
                        }
                    },
                    {
                        "ref-fulltext": "Team RDC. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84863304598",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Vienna, Austria: R Foundation for Statistical Computing",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Team RDC",
                                "ce:indexed-name": "Team RDC"
                            }},
                            "ref-sourcetitle": "A Language and Environment for Statistical Computing"
                        }
                    },
                    {
                        "ref-fulltext": "Ungar B, Kopylov U, Yavzori M, et al. Association of vedolizumab level, antidrug antibodies, and α4β7 occupancy with response in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16:697-705.e7.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Association of vedolizumab level, antidrug antibodies, and α4β7 occupancy with response in patients with inflammatory bowel diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044300990",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "697",
                                    "@last": "705"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Ungar",
                                        "ce:indexed-name": "Ungar B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Kopylov",
                                        "ce:indexed-name": "Kopylov U."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Yavzori",
                                        "ce:indexed-name": "Yavzori M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol."
                        }
                    },
                    {
                        "ref-fulltext": "Van Stappen T, Vande Casteele N, Van Assche G, et al. Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial. Gut. 2018;67:818-826.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: Post hoc analysis of the TAXIT trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85046490601",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "818",
                                    "@last": "826"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Van-Stappen",
                                        "ce:indexed-name": "Van-Stappen T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Vande-Casteele",
                                        "ce:indexed-name": "Vande-Casteele N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Van-Assche",
                                        "ce:indexed-name": "Van-Assche G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        }
                    },
                    {
                        "ref-fulltext": "Rosario M, Dirks NL, Gastonguay MR, et al. Population pharmacokinetics- pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease. Aliment Pharmacol Ther. 2015;42:188-202.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics- pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84931563838",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "188",
                                    "@last": "202"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Rosario",
                                        "ce:indexed-name": "Rosario M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Dirks",
                                        "ce:indexed-name": "Dirks N.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Gastonguay",
                                        "ce:indexed-name": "Gastonguay M.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther."
                        }
                    },
                    {
                        "ref-fulltext": "Dotan I, Ron Y, Yanai H, et al. Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study. Inflamm Bowel Dis. 2014;20:2247-2259.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: A population pharmacokinetic study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925759693",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "2247",
                                    "@last": "2259"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Dotan",
                                        "ce:indexed-name": "Dotan I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ron",
                                        "ce:indexed-name": "Ron Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Yanai",
                                        "ce:indexed-name": "Yanai H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis."
                        }
                    },
                    {
                        "ref-fulltext": "Sharma S, Eckert D, Hyams JS, et al. Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's disease: results from a randomized, multicenter, phase-3 study. Inflamm Bowel Dis. 2015;21:783-792.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's disease: Results from a randomized, multicenter, phase-3 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925400536",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "783",
                                    "@last": "792"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sharma",
                                        "ce:indexed-name": "Sharma S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Eckert",
                                        "ce:indexed-name": "Eckert D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hyams",
                                        "ce:indexed-name": "Hyams J.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis."
                        }
                    },
                    {
                        "ref-fulltext": "Colombel JF, Sandborn WJ, Allez M, et al. Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease. Clin Gastroenterol Hepatol. 2014;12:423-431.e1.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84893898345",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "423",
                                    "@last": "431"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel J.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn W.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Allez",
                                        "ce:indexed-name": "Allez M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol."
                        }
                    },
                    {
                        "ref-fulltext": "Xu ZH, Lee H, Vu T, et al. Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity. Int J Clin Pharmacol Ther. 2010;48:596-607.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: Impact of body weight and immunogenicity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77956930841",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "48"},
                                "pagerange": {
                                    "@first": "596",
                                    "@last": "607"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu Z.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Vu",
                                        "ce:indexed-name": "Vu T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Pharmacol Ther."
                        }
                    },
                    {
                        "ref-fulltext": "Bhalme M, Sharma A, Keld R, et al. Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease? Eur J Gastroenterol Hepatol. 2013;25:543-549.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84876414678",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "543",
                                    "@last": "549"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bhalme",
                                        "ce:indexed-name": "Bhalme M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sharma",
                                        "ce:indexed-name": "Sharma A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Keld",
                                        "ce:indexed-name": "Keld R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Gastroenterol Hepatol."
                        }
                    },
                    {
                        "ref-fulltext": "Puig L. Obesity and psoriasis: body weight and body mass index influence the response to biological treatment. J Eur Acad Dermatol Venereol. 2011;25:1007-1011.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Obesity and psoriasis: Body weight and body mass index influence the response to biological treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80051703774",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "1007",
                                    "@last": "1011"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "ce:surname": "Puig",
                                "ce:indexed-name": "Puig L."
                            }]},
                            "ref-sourcetitle": "J Eur Acad Dermatol Venereol."
                        }
                    },
                    {
                        "ref-fulltext": "Rosario M, French JL, Dirks NL, et al. Exposure-efficacy relationships for vedolizumab induction therapy in patients with ulcerative colitis or Crohn's disease. J Crohns Colitis. 2017;11:921-929.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Exposure-efficacy relationships for vedolizumab induction therapy in patients with ulcerative colitis or Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85035065711",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "921",
                                    "@last": "929"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Rosario",
                                        "ce:indexed-name": "Rosario M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.L.",
                                        "@_fa": "true",
                                        "ce:surname": "French",
                                        "ce:indexed-name": "French J.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Dirks",
                                        "ce:indexed-name": "Dirks N.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis."
                        }
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85061989001",
        "dc:description": "Background/Aims: The clinical utility of vedolizumab (VDZ) trough levels (VTLs) in inflammatory bowel disease (IBD) is not well defined. The aims of this study are to determine the median VTLs and frequency of detected antibodies, the correlation of VTLs with C-reactive protein (CRP) and mucosal healing (MH), and the change in clinical management based on VTLs. Methods: A cross-sectional study of IBD patients treated with VDZ with VTLs checked between July 1, 2016, and March 1, 2017, was conducted. Mucosal healing was defined as absence of mucosal ulcers in Crohn's disease (CD) and Mayo endoscopic score ≤1 for ulcerative colitis (UC). Normal CRP was defined as ≤8 mg/L. Results: A total of 171 patients (62% CD, 31% UC, 7% indeterminate colitis) were included. Median VTLs was 15.3 ug/mL (range, 0-60), and 1 patient had detectable antibodies to VDZ. Patients with a normal CRP had a median VTLs of 17.3 ug/mL vs 10.7 ug/mL in high CRP patients (P = 0.046). This was noted in CD (20.3 vs 10.4 ug/mL; P = 0.005) but not in UC patients (14.4 vs 20.8; P = 0.72). Mucosal healing was achieved in 35% of patients (37 of 105); among these, median VTLs was 13.7 ug/mL vs 16.1 ug/mL in patients who did not achieve MH (P = 0.64). Vedolizumab trough levels resulted in a change in clinical management in 73%. Conclusions: Our cohort showed a low rate of immunogenicity to VDZ and an association between VTLs and CRP in CD but not in UC patients. No relationship between VTLs and MH was detected. Vedolizumab trough level measurements altered management in approximately three fourths of patients.",
        "pubmed-id": "30165638",
        "prism:coverDate": "2019-02-21",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85061989001",
        "dc:creator": {"author": [{
            "ce:given-name": "Badr",
            "preferred-name": {
                "ce:given-name": "Badr",
                "ce:initials": "B.",
                "ce:surname": "Al-Bawardy",
                "ce:indexed-name": "Al-Bawardy B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Al-Bawardy",
            "@auid": "56217996100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56217996100",
            "ce:indexed-name": "Al-Bawardy B."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85061989001"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061989001&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85061989001&origin=inward"
            }
        ],
        "source-id": "28387",
        "citedby-count": "32",
        "prism:volume": "25",
        "subtype": "ar",
        "dc:title": "Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease",
        "openaccess": "0",
        "prism:issn": "15364844 10780998",
        "publishercopyright": "© 2018 Crohn's & Colitis Foundation.",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "Inflammatory Bowel Diseases",
        "prism:pageRange": "580-586",
        "prism:endingPage": "586",
        "openaccessFlag": "false",
        "prism:doi": "10.1093/ibd/izy272",
        "prism:startingPage": "580",
        "dc:identifier": "SCOPUS_ID:85061989001",
        "dc:publisher": "Oxford University Press"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adolescent",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged, 80 and over",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antibodies, Monoclonal, Humanized",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Biomarkers",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Child",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Child, Preschool",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cross-Sectional Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Follow-Up Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gastrointestinal Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Inflammatory Bowel Diseases",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Mucous Membrane",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prognosis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Retrospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Wound Healing",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Young Adult",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "inflammatory bowel disease"
        },
        {
            "@_fa": "true",
            "$": "therapeutic drug monitoring"
        },
        {
            "@_fa": "true",
            "$": "vedolizumab"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Badr",
            "preferred-name": {
                "ce:given-name": "Badr",
                "ce:initials": "B.",
                "ce:surname": "Al-Bawardy",
                "ce:indexed-name": "Al-Bawardy B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Al-Bawardy",
            "@auid": "56217996100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56217996100",
            "ce:indexed-name": "Al-Bawardy B."
        },
        {
            "ce:given-name": "Guilherme Piovezani",
            "preferred-name": {
                "ce:given-name": "Guilherme Piovezani",
                "ce:initials": "G.P.",
                "ce:surname": "Ramos",
                "ce:indexed-name": "Ramos G.P."
            },
            "@seq": "2",
            "ce:initials": "G.P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Ramos",
            "@auid": "57189043639",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189043639",
            "ce:indexed-name": "Ramos G.P."
        },
        {
            "ce:given-name": "Maria Alice V.",
            "preferred-name": {
                "ce:given-name": "Maria Alice V.",
                "ce:initials": "M.A.V.",
                "ce:surname": "Willrich",
                "ce:indexed-name": "Willrich M.A.V."
            },
            "@seq": "3",
            "ce:initials": "M.A.V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "Ph.D.",
            "ce:surname": "Willrich",
            "@auid": "56736400500",
            "author-url": "https://api.elsevier.com/content/author/author_id/56736400500",
            "ce:indexed-name": "Willrich M.A.V."
        },
        {
            "ce:given-name": "Sarah M.",
            "preferred-name": {
                "ce:given-name": "Sarah M.",
                "ce:initials": "S.M.",
                "ce:surname": "Jenkins",
                "ce:indexed-name": "Jenkins S.M."
            },
            "@seq": "4",
            "ce:initials": "S.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MS",
            "ce:surname": "Jenkins",
            "@auid": "34770162500",
            "author-url": "https://api.elsevier.com/content/author/author_id/34770162500",
            "ce:indexed-name": "Jenkins S.M."
        },
        {
            "ce:given-name": "Sang Hyoung",
            "preferred-name": {
                "ce:given-name": "Sang Hyoung",
                "ce:initials": "S.H.",
                "ce:surname": "Park",
                "ce:indexed-name": "Park S.H."
            },
            "@seq": "5",
            "ce:initials": "S.H.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60005558",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
                },
                {
                    "@id": "60006240",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Park",
            "@auid": "34977204700",
            "author-url": "https://api.elsevier.com/content/author/author_id/34977204700",
            "ce:indexed-name": "Park S.H."
        },
        {
            "ce:given-name": "Satimai",
            "preferred-name": {
                "ce:given-name": "Satimai",
                "ce:initials": "S.",
                "ce:surname": "Aniwan",
                "ce:indexed-name": "Aniwan S."
            },
            "@seq": "6",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60005558",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Aniwan",
            "@auid": "36010544000",
            "author-url": "https://api.elsevier.com/content/author/author_id/36010544000",
            "ce:indexed-name": "Aniwan S."
        },
        {
            "ce:given-name": "Shayla A.",
            "preferred-name": {
                "ce:given-name": "Shayla A.",
                "ce:initials": "S.A.",
                "ce:surname": "Schoenoff",
                "ce:indexed-name": "Schoenoff S.A."
            },
            "@seq": "7",
            "ce:initials": "S.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:surname": "Schoenoff",
            "@auid": "57204044045",
            "author-url": "https://api.elsevier.com/content/author/author_id/57204044045",
            "ce:indexed-name": "Schoenoff S.A."
        },
        {
            "ce:given-name": "David H.",
            "preferred-name": {
                "ce:given-name": "David H.",
                "ce:initials": "D.H.",
                "ce:surname": "Bruining",
                "ce:indexed-name": "Bruining D.H."
            },
            "@seq": "8",
            "ce:initials": "D.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Bruining",
            "@auid": "16833358400",
            "author-url": "https://api.elsevier.com/content/author/author_id/16833358400",
            "ce:indexed-name": "Bruining D.H."
        },
        {
            "ce:given-name": "Konstantinos A.",
            "preferred-name": {
                "ce:given-name": "Konstantinos A.",
                "ce:initials": "K.A.",
                "ce:surname": "Papadakis",
                "ce:indexed-name": "Papadakis K.A."
            },
            "@seq": "9",
            "ce:initials": "K.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Papadakis",
            "@auid": "19335444300",
            "author-url": "https://api.elsevier.com/content/author/author_id/19335444300",
            "ce:indexed-name": "Papadakis K.A."
        },
        {
            "ce:given-name": "Laura",
            "preferred-name": {
                "ce:given-name": "Laura",
                "ce:initials": "L.",
                "ce:surname": "Raffals",
                "ce:indexed-name": "Raffals L."
            },
            "@seq": "10",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Raffals",
            "@auid": "54986410100",
            "author-url": "https://api.elsevier.com/content/author/author_id/54986410100",
            "ce:indexed-name": "Raffals L."
        },
        {
            "ce:given-name": "William J.",
            "preferred-name": {
                "ce:given-name": "William J.",
                "ce:initials": "W.J.",
                "ce:surname": "Tremaine",
                "ce:indexed-name": "Tremaine W.J."
            },
            "@seq": "11",
            "ce:initials": "W.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Tremaine",
            "@auid": "7006301261",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006301261",
            "ce:indexed-name": "Tremaine W.J."
        },
        {
            "ce:given-name": "Edward V.",
            "preferred-name": {
                "ce:given-name": "Edward V.",
                "ce:initials": "E.V.",
                "ce:surname": "Loftus",
                "ce:indexed-name": "Loftus E.V."
            },
            "@seq": "12",
            "ce:initials": "E.V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Loftus",
            "@auid": "7202138774",
            "ce:suffix": "Jr.",
            "author-url": "https://api.elsevier.com/content/author/author_id/7202138774",
            "ce:indexed-name": "Loftus E.V."
        }
    ]}
}}